Section 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

PRODUCT NAME

MALVIDIN 3-GALACTOSIDE HEMIHENDECAHYDRATE

NFPA

PRODUCT USE

Anthocyanoside extracted from plants. Anthocyanidins and anthocyanosides, of which they
are part, are used (as plant extracts) in the treatment of visual disorders.Clinical
applications include: · Alteration to the micro- circulation · Alteration of peripheral
venous circulation (treatment of chronic venous insufficiency and hemorrhoids) · Gastric
and duodenal injury · Visual disorders due to impaired photosensitivity in diabetic
retinopathy.

SYNONYMS

C23-H25-Cl-O12, primulin, "3, 5-diglucoside of:", "3, 5-diglucoside of:", "flavylium, 3,
4'5, 7-tetrahydroxy-3', 5'-dimethoxy-, chloride", "flavylium, 3, 4'5, 7-tetrahydroxy-3',
5'-dimethoxy-, chloride", "1-benzopyrylium, 3, 5, 7-trihydroxy-2-(4-hydroxy-3, 5-
dimethoxyphenyl)-, chloride", "1-benzopyrylium, 3, 5, 7-trihydroxy-2-(4-hydroxy-3, 5-
dimethoxyphenyl)-, chloride", "benzopyrylium, ", "3, 5, 7-trihydroxy-2-(4-hydroxy-3, 5-
dimethoxyphenyl)-, chloride", "3, 5, 7-trihydroxy-2-(4-hydroxy-3, 5-dimethoxyphenyl)-,
chloride", "3, 5, 7-trihydroxy-2-(4-hydroxy-3, 5-dimethoxyphenyl)-1-benzopyrylium
chloride", "3, 5, 7-trihydroxy-2-(4-hydroxy-3, 5-dimethoxyphenyl)-1-benzopyrylium
chloride", "3', 5'-dimethoxy-3, 4'-5, 7-tetrahydroxyflavium chloride", "3', 5'-dimethoxy-
3, 4'-5, 7-tetrahydroxyflavium chloride", "3, 4', 5, 7-tetrahydroxy-3', 5'-
dimethoxyflavylium chloride", "3, 4', 5, 7-tetrahydroxy-3', 5'-dimethoxyflavylium
chloride", "3, 4', 5, 7-tetrahydroxy-3', 5'-dimethoxy-2-phenylbenzopyrylium chloride", "3,
4', 5, 7-tetrahydroxy-3', 5'-dimethoxy-2-phenylbenzopyrylium chloride", anthocyanoside,
"anthocyanidin flavonoid", "natural product"

Section 2 - HAZARDS IDENTIFICATION

CANADIAN WHMIS SYMBOLS

EMERGENCY OVERVIEW

RISK

POTENTIAL HEALTH EFFECTS

ACUTE HEALTH EFFECTS

SWALLOWED

  Although ingestion is not thought to produce harmful effects, the material may still be damaging to the health of the individual following ingestion, especially where pre-  existing organ (e.g. liver, kidney) damage is evident. Present definitions of harmful or toxic substances are generally based on doses producing mortality (death) rather than those producing morbidity (disease, ill-health). Gastrointestinal tract discomfort may produce nausea and vomiting. In an occupational setting however, ingestion of insignificant quantities is not thought to be cause for concern.  Anthrocyanosides are rapidly absorbed and eliminated; in low oral doses, long term toxicity is not significant.  

EYE

  Although the material is not thought to be an irritant, direct contact with the eye may produce transient discomfort characterized by tearing or conjunctival redness (as with windburn).  

SKIN

  The material is not thought to produce adverse health effects or skin irritation following contact (as classified using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable gloves be used in an occupational setting.  

INHALED

  The material is not thought to produce adverse health effects or irritation of the respiratory tract (as classified using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable control measures be used in an occupational setting.  Persons with impaired respiratory function, airway diseases and conditions such as emphysema or chronic bronchitis, may incur further disability if excessive concentrations of particulate are inhaled.  

CHRONIC HEALTH EFFECTS

  Principal routes of exposure are by accidental skin and eye contact andinhalation of generated dusts.  Injected anthocyanosides has been reputed to cause a lowering of the incidence of gastric ulcer and increase capillary permeability. They have not been shown to cause cancer or mutations.  Flavonoids, which are found in a range of foods and medicines, has been shown to cause leukemia in infancy, but, if taken at high levels in the diet, they reduce the risk of breast and prostate cancer.